Stock Taper

Pricing Sign Up Log In

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR

Amplify Weight Loss Drug & Treatment ETF • Amplify

$25.88 ▲ 1.70% (+0.43)

Managing Company Amplify

Asset Under Management $5.13M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $27.28

52w Low $21.70

Volume 426

Avg Volume 1,955

Asset Class Equity

About Amplify Weight Loss Drug & Treatment ETF

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.

Managing Company Amplify

Asset Under Management $5.13M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $27.28

52w Low $21.70

Volume 426

Avg Volume 1,955

Asset Class Equity

About Amplify Weight Loss Drug & Treatment ETF

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
NVO	Novo Nordisk A/S	10.11%	10.45K	$512.63K
LLY	Eli Lilly and Company	8.96%	394	$454.10K
HIMS	Hims & Hers Health, Inc.	5.72%	8.25K	$289.95K
SRRK	Scholar Rock Holding Corporation	5.65%	5.33K	$286.59K
VKTX	Viking Therapeutics, Inc.	5.41%	7.22K	$274.33K
REGN	Regeneron Pharmaceuticals, Inc.	5.19%	401	$263.10K
ABBV	AbbVie Inc.	5.08%	1.06K	$257.63K
AMGN	Amgen Inc.	4.84%	691	$245.48K
MRK	Merck & Co., Inc.	4.70%	1.97K	$238.06K
ARWR	Arrowhead Pharmaceuticals, Inc.	4.54%	3.20K	$230.25K
PFE	Pfizer Inc.	4.48%	9.36K	$227.00K
AZN	AstraZeneca PLC	4.36%	1.34K	$221.09K
KLRA	Kailera Therapeutics, Inc.	2.15%	5.72K	$108.78K

SECTOR HOLDINGS

Healthcare

Healthcare

98.70%

Cash & Others

Cash & Others

0.84%

Financial Services

Financial Services

0.46%

ASSET ALLOCATION BY REGION

United States

57.04%

Denmark

13.35%

China

13.07%

Switzerland

4.86%

United Kingdom

4.46%

Japan

4.46%

South Korea

2.01%

Other

0.76%

SECTOR HOLDINGS

Healthcare

Healthcare

98.70%

Cash & Others

Cash & Others

0.84%

Financial Services

Financial Services

0.46%

ASSET ALLOCATION BY REGION

United States

57.04%

Denmark

13.35%

China

13.07%

Switzerland

4.86%

United Kingdom

4.46%

Japan

4.46%

South Korea

2.01%

Other

0.76%

Holdings (Top 20)

NVO

NVO

Novo Nordisk A/S

Weight: 10.11% Shares: 10.45K Value: $512.63K

LLY

LLY

Eli Lilly and Company

Weight: 8.96% Shares: 394 Value: $454.10K

HIMS

HIMS

Hims & Hers Health, Inc.

Weight: 5.72% Shares: 8.25K Value: $289.95K

SRRK

SRRK

Scholar Rock Holding Corporation

Weight: 5.65% Shares: 5.33K Value: $286.59K

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 5.41% Shares: 7.22K Value: $274.33K

REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 5.19% Shares: 401 Value: $263.10K

ABBV

ABBV

AbbVie Inc.

Weight: 5.08% Shares: 1.06K Value: $257.63K

AMGN

AMGN

Amgen Inc.

Weight: 4.84% Shares: 691 Value: $245.48K

MRK

MRK

Merck & Co., Inc.

Weight: 4.70% Shares: 1.97K Value: $238.06K

ARWR

ARWR

Arrowhead Pharmaceuticals, Inc.

Weight: 4.54% Shares: 3.20K Value: $230.25K

PFE

PFE

Pfizer Inc.

Weight: 4.48% Shares: 9.36K Value: $227.00K

AZN

AZN

AstraZeneca PLC

Weight: 4.36% Shares: 1.34K Value: $221.09K

KLRA

KLRA

Kailera Therapeutics, Inc.

Weight: 2.15% Shares: 5.72K Value: $108.78K